Since we did not observe any overt toxicity with rhododendrin treatment, RNF146 induction and PARP1 inhibition by rhododendrin could serve as a safe therapeutic strategy to halt PARP1-dependent dopaminergic neuron demise in PD. Here, PARP1 is linked to Parkinson disease.